Clarus Therapeutics

Recent Finacing

Debt

Recent Raise

$75M

Clarus Therapeutics develops and commercializes oral softgel testosterone undecanoate capsules (JATENZO/REXTORO) for treating male hypogonadism and holds worldwide commercialization and patent rights.

Founded 2003

Illinois, United States

11-50

Publicly Traded

clarustherapeutics.com

Highlights

Focus Areas

Biotechnology

Health Care

Life Science

Therapeutics

Recent Investors

Financials

$106.5M

Total Raised

2

Funding rounds

3

Investors

Team

Upgrade to view the team

See the team members at Clarus Therapeutics.